- Press release
Tempo Therapeutics Awarded $2.25 Million NIH SBIR Grant to Advance MAP™ Technology for Complex Wound Healing
Novel synthetic biomaterial is designed to support volumetric tissue regeneration while minimizing inflammatory foreign-body response
